Dr. Ramaswamy Discusses Tumor Heterogeneity

Video

Dr. Sridhar Ramaswamy from the Massachusetts General Hospital Cancer Center Discusses Tumor Heterogeneity

Sridhar Ramaswamy, MD, Tucker Gosnell Investigator and Associate Professor of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Broad Institute of Harvard & MIT, and Harvard Stem Cell Institute, explains that every tumor, no matter what type, displays a certain degree of heterogeneity.

Heterogeneous cells can vary on both a molecular and genetic basis. Some cells differentiate on a cellular level by displaying various patches on the cell surface that are different than the rest of the cell. Cellular disparity may contribute to tumor recurrence and therapy resistance.

When examining the cells, different classifications arise. Some are pre-apoptotic and are near the point of programmed cell death; this type will not cause issues in the future. Other cells are senescent, which do not proliferate. The most interesting set are the sleeping or dormant cells, which can be implicated in drug tolerance. Sleeping cells are particularly interesting because of their ability to move in and out of the dormant state.

Ramaswamy notes that understanding the mechanism of heterogeneity may help understand the dynamics of tumor growth, which could lead to a more sustainable drug response.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute